Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Irritable Bowel Syndrome Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global irritable bowel syndrome treatment market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Irritable bowel syndrome (IBS) refers to a chronic medical condition that affects the large intestine. It is usually caused by severe infection, stressful lifestyle, changes in gut microbes, muscle contractions in the intestine, and abnormalities in the nervous system. It can be characterized by gas, diarrhea, cramping, bloating, constipation, weight loss, vomiting, abdominal pain, and difficulty in swallowing. Several medications are currently available to relieve mild symptoms of IBS, including rifaximin, loperamide, laxatives, antispasmodics, fiber supplements, and coated peppermint oil capsules. Doctors also recommend probiotics and mental health therapies, such as cognitive behavioral-therapy (CBT), gut-directed hypnotherapy, and relaxation training, to treat certain patients.

Irritable Bowel Syndrome Treatment Market Trends:

Several factors increase the risk of IBS diseases, including food intolerances or sensitivities, bacterial infections in the digestive tract, small intestinal bacterial overgrowth, and mental disorders like anxiety, depression, and somatic symptom. This, along with improving diagnostic modalities and easy access to healthcare services, represents one of the key factors bolstering the growth of the market. Furthermore, IBS is one of the most common functional gastrointestinal disorders among the elderly. In confluence with this, the rising geriatric population across the globe is influencing the market positively. Besides this, several clinical trials, such as fecal microbiota transplantation (FMT), are being conducted to improve the treatment of IBS, which is contributing to market growth. In addition to this, as part of the Sustainable Development Goals (SDGs), governing agencies of various countries have pledged to substantially increase spending on research and development (R&D) projects and the number of researchers by 2030. This, in turn, is projected to expand the number of potential treatment options for IBS in the future.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global irritable bowel syndrome treatment market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on type, product and distribution channel.

Breakup by Type:

  • IBS with Diarrhea (IBS-D)
  • IBS with Constipation (IBS-C)
  • Mixed IBS
     

Breakup by Product:

  • Rifaximin
  • Eluxadoline
  • Lubiprostone
  • Linaclotide
  • Others
     

Breakup by Distribution Channel:

  • Hospitals Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Stores
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Allergan plc (AbbVie Inc.), Ardelyx Inc., Astellas Pharma Inc., AstraZeneca plc, Bausch Health Companies Inc., GlaxoSmithKline Plc, Novartis AG, Sebela Pharmaceuticals Inc., Synthetic Biologics Inc. and Takeda Pharmaceutical Company Limited.

Report Coverages:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Type, Product, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Allergan plc (AbbVie Inc.), Ardelyx Inc., Astellas Pharma Inc., AstraZeneca plc, Bausch Health Companies Inc., GlaxoSmithKline Plc, Novartis AG, Sebela Pharmaceuticals Inc., Synthetic Biologics Inc. and Takeda Pharmaceutical Company Limited.
Customization Scope 10% Free Customization
Report Price and Purchase Option                                     Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global irritable bowel syndrome treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global irritable bowel syndrome treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global irritable bowel syndrome treatment market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Irritable Bowel Syndrome Treatment Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Type
    6.1    IBS with Diarrhea (IBS-D)
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    IBS with Constipation (IBS-C)
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Mixed IBS
        6.3.1 Market Trends
        6.3.2 Market Forecast
7    Market Breakup by Product
    7.1    Rifaximin
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Eluxadoline
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Lubiprostone
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Linaclotide
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8    Market Breakup by Distribution Channel
    8.1    Hospitals Pharmacies
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Drug Stores and Retail Pharmacies
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Online Stores
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Abbott Laboratories
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Allergan plc (AbbVie Inc.)
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    Ardelyx Inc.
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
        14.3.4    Astellas Pharma Inc.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    AstraZeneca plc
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Bausch Health Companies Inc.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    GlaxoSmithKline Plc
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Novartis AG
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Sebela Pharmaceuticals Inc.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
        14.3.10    Synthetic Biologics, Inc.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
        14.3.11    Takeda Pharmaceutical Company Limited
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials
           14.3.11.4 SWOT Analysis

List of Figures

Figure 1: Global: Irritable Bowel Syndrome Treatment Market: Major Drivers and Challenges
Figure 2: Global: Irritable Bowel Syndrome Treatment Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Type (in %), 2020
Figure 5: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Product (in %), 2020
Figure 6: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Distribution Channel (in %), 2020
Figure 7: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Region (in %), 2020
Figure 8: Global: Irritable Bowel Syndrome Treatment (IBS with Diarrhea (IBS-D)) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Irritable Bowel Syndrome Treatment (IBS with Diarrhea (IBS-D)) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Irritable Bowel Syndrome Treatment (IBS with Constipation (IBS-C)) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Irritable Bowel Syndrome Treatment (IBS with Constipation (IBS-C)) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Irritable Bowel Syndrome Treatment (Mixed IBS) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Irritable Bowel Syndrome Treatment (Mixed IBS) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Irritable Bowel Syndrome Treatment (Rifaximin) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Irritable Bowel Syndrome Treatment (Rifaximin) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Irritable Bowel Syndrome Treatment (Eluxadoline) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Irritable Bowel Syndrome Treatment (Eluxadoline) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Irritable Bowel Syndrome Treatment (Lubiprostone) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Irritable Bowel Syndrome Treatment (Lubiprostone) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Irritable Bowel Syndrome Treatment (Linaclotide) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Irritable Bowel Syndrome Treatment (Linaclotide) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Irritable Bowel Syndrome Treatment (Other Products) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Irritable Bowel Syndrome Treatment (Other Products) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Irritable Bowel Syndrome Treatment (Hospitals Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Irritable Bowel Syndrome Treatment (Hospitals Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Irritable Bowel Syndrome Treatment (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Irritable Bowel Syndrome Treatment (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Irritable Bowel Syndrome Treatment (Online Stores) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Irritable Bowel Syndrome Treatment (Online Stores) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: North America: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: North America: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: United States: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: United States: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Canada: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Canada: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Asia-Pacific: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Asia-Pacific: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: China: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: China: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: Japan: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: Japan: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: India: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: India: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: South Korea: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: South Korea: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Australia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Australia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Indonesia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Indonesia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Europe: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Europe: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Germany: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Germany: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: France: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: France: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: United Kingdom: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: United Kingdom: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Italy: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Italy: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Spain: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Spain: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Russia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Russia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Latin America: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Latin America: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Brazil: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Brazil: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Mexico: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Mexico: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Middle East and Africa: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Middle East and Africa: Irritable Bowel Syndrome Treatment Market: Breakup by Country (in %), 2020
Figure 78: Middle East and Africa: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Global: Irritable Bowel Syndrome Treatment Industry: SWOT Analysis
Figure 80: Global: Irritable Bowel Syndrome Treatment Industry: Value Chain Analysis
Figure 81: Global: Irritable Bowel Syndrome Treatment Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Irritable Bowel Syndrome Treatment Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Type (in Million US$), 2021-2026
Table 3: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Product (in Million US$), 2021-2026
Table 4: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 5: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Irritable Bowel Syndrome Treatment Market: Competitive Structure
Table 7: Global: Irritable Bowel Syndrome Treatment Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links